The Department has a diverse research programme: managing people with ultra-high risk of developing psychosis, ethiopathogenesis and treatment of schizophrenia (particularly early psychosis) and affective disorders. Our main research interests are:

  • The role of oxidative stress role in the pathogenesis of schizophrenia
  • The influence of antipsychotics on oxidative stress
  • White matter changes in early psychosis
  • The role of polyunsaturated fatty acids omega-3 in the etiopathogenesis and treatment of schizophrenia
  • The role of dopaminergic agonists in the treatment of schizophrenia with dominating negative symptoms
  • At risk mental state for psychosis. Triggers of conversion to psychosis
  • Schizophrenia markers